{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)
Status:
Investigational
Source:
NCT03123055: Phase 1/Phase 2 Interventional Terminated Locally Advanced or Metastatic Urothelial Cell Carcinoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03697304: Phase 2 Interventional Completed Neoplasm Metastasis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04028063: Phase 2 Interventional Recruiting Metastatic Soft Tissue Sarcoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03989362: Phase 2 Interventional Completed Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04097821: Phase 1/Phase 2 Interventional Completed Myelofibrosis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04557020: Phase 3 Interventional Recruiting Nasopharyngeal Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02472145: Phase 2/Phase 3 Interventional Completed Leukemia, Myeloid, Acute
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sirtratumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01963052: Phase 1 Interventional Completed Metastatic Urothelial Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04620811: Phase 3 Interventional Completed Eosinophilic Gastritis
(2020)
Source URL:
Class:
PROTEIN